Detalles de la búsqueda
1.
Discovery and Evaluation of C6-Substituted Pyrazolopyrimidine-Based Bisphosphonate Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase and Evaluation of Their Antitumor Efficacy in Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and Colorectal Cancer.
J Med Chem
; 66(23): 15776-15800, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982711
2.
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy.
Cell Rep
; 39(1): 110634, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385748
3.
Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.
Clin Cancer Res
; 27(12): 3432-3442, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593882
4.
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas.
Clin Cancer Res
; 24(24): 6483-6494, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903896
Resultados
1 -
4
de 4
1
Próxima >
>>